About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see rising health care costs

President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out

About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see rising health care costs